Psychoactive Medicine Consumption in Brazil Before and During COVID-19

21.5 KB of data tracks Defined Daily Dose consumption per 1,000 inhabitants per day in Brazil and its regions. Evani Leite de Freitas published this dataset on figshare under a CC-BY-4.0 license. The dataset compares selected periods before and during the COVID-19 pandemic.

Use Cases

• Analyze changes in psychoactive medicine consumption based on the pre- and post-pandemic periods mentioned in the description
• Compare regional disparities in drug use across Brazil based on the regional breakdown
• Study the public health impact of the COVID-19 pandemic based on pharmaceutical consumption metrics
• Benchmark drug consumption rates using the standardized Defined Daily Dose (DDD) metric

Strengths

• Data is licensed as CC-BY-4.0, allowing for broad reuse.
• The 21.5 KB file size suggests a focused, manageable dataset for analysis.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Time Range

Selected periods before and during the COVID-19 pandemic.

Freshness

Last updated 2026-05-11 17:51:37; freshness should be verified.

Geography

Brazil and its regions.